Earlier this year, the U.S. Food and Drug Administration (FDA) convened an inter-governmental working meeting of state government officials to identify opportunities to better protect the public health by strengthening oversight of compounders, including through improved federal-state collaboration.
During this meeting, participants discussed oversight of compounding pharmacies and implementation of the Drug Quality and Security Act (DQSA). The DQSA, P.L. 113-54, was signed into law on November 27, 2013, and contains provisions relating to federal and state oversight of compounded human drugs.
This post has features the meeting agenda, summary of events and presentations from panel experts. http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm393633.htm